SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-003161
Filing Date
2024-03-14
Accepted
2024-03-14 07:03:11
Documents
103
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K plx-20231231x10k.htm   iXBRL 10-K 2396739
2 EX-4.7 plx-20231231xex4d7.htm EX-4.7 17970
3 EX-23.1 plx-20231231xex23d1.htm EX-23.1 7696
4 EX-31.1 plx-20231231xex31d1.htm EX-31.1 11426
5 EX-31.2 plx-20231231xex31d2.htm EX-31.2 11088
6 EX-32.1 plx-20231231xex32d1.htm EX-32.1 5656
7 EX-32.2 plx-20231231xex32d2.htm EX-32.2 5563
8 EX-97.1 plx-20231231xex97d1.htm EX-97.1 47446
9 GRAPHIC plx-20231231x10k001.jpg GRAPHIC 39262
10 GRAPHIC plx-20231231x10k002.jpg GRAPHIC 45532
11 GRAPHIC plx-20231231x10k003.jpg GRAPHIC 53801
12 GRAPHIC plx-20231231x10k004.jpg GRAPHIC 49031
13 GRAPHIC plx-20231231x10k005.jpg GRAPHIC 38704
14 GRAPHIC plx-20231231x10k007.jpg GRAPHIC 3480
15 GRAPHIC plx-20231231xex23d1001.jpg GRAPHIC 4679
  Complete submission text file 0001558370-24-003161.txt   10122213

Data Files

Seq Description Document Type Size
16 EX-101.SCH plx-20231231.xsd EX-101.SCH 67288
17 EX-101.CAL plx-20231231_cal.xml EX-101.CAL 65092
18 EX-101.DEF plx-20231231_def.xml EX-101.DEF 276625
19 EX-101.LAB plx-20231231_lab.xml EX-101.LAB 483525
20 EX-101.PRE plx-20231231_pre.xml EX-101.PRE 465963
105 EXTRACTED XBRL INSTANCE DOCUMENT plx-20231231x10k_htm.xml XML 1490779
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 24747895
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)